journal article·2020-08Open access

Self‐Degradable Lipid‐Like Materials Based on “Hydrolysis accelerated by the intra‐Particle Enrichment of Reactant (HyPER)” for Messenger RNA Delivery

Hiroki Tanaka, Tatsunari Takahashi, Manami Konishi, Nae Takata, Masaki Gomi, Daiki Shirane, Ryo Miyama, Shinya Hagiwara, Yuki Yamasaki, Yu Sakurai, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Eiji Shinsho, Ruka Nishida, Kaori Fukuzawa, Etsuo Yonemochi, Koji Okuwaki, Yuji Mochizuki, Yuta Nakai, Kota Tange, Hiroki Yoshioka, Shinya Tamagawa, Hidetaka Akita

Advanced Functional Materials· Volume 30· Issue 34

Abstract

Abstract RNA‐based therapeutics is a promising approach for curing intractable diseases by manipulating various cellular functions. For eliciting RNA (i.e., mRNA and siRNA) functions successfully, the RNA in the extracellular space must be protected and it must be delivered to the cytoplasm. In this study, the development of a self‐degradable lipid‐like material that functions to accelerate the collapse of lipid nanoparticles (LNPs) and the release of RNA into cytoplasm is reported. The self‐degradability is based on a unique reaction “Hydrolysis accelerated by intra‐Particle Enrichment of Reactant (HyPER).” In this reaction, a disulfide bond and a phenyl ester are essential structural components: concentrated hydrophobic thiols that are produced by the cleavage of the disulfide bonds in the LNPs drive an intraparticle nucleophilic attack to the phenyl ester linker, which results in further degradation. An oleic acid‐scaffold lipid‐like material that mounts all of these units (ssPalmO‐Phe) shows superior transfection efficiency to nondegradable or conventional materials. The insertion of the aromatic ring is unexpectedly revealed to contribute to the enhancement of endosomal escape. Since the intracellular trafficking is a sequential process that includes cellular uptake, endosomal escape, the release of mRNA, and translation, the improvement in each process synergistically enhances the gene expression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · RNA Research and Splicing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of DDS Design and Drug Disposition Graduate School of Pharmaceutical Sciences Chiba University 1‐8‐1 Inohana, Chuo‐ku Chiba Chiba 260‐0856 Japan

Laboratory of Pharmaceutical Technology Graduate School of Pharmaceutical Sciences Chiba University 1‐8‐1, Inohana, Chuo‐ku Chiba Chiba 260‐0856 Japan

School of Pharmacy and Pharmaceutical Sciences Hoshi University 2‐4‐41, Ebara, Shinagawa Tokyo 145‐8501 Japan

Institute of Industrial Science The University of Tokyo 4‐6‐1 Komaba, Meguro‐ku Tokyo 153‐8505 Japan

Department of Chemistry and Research Center for Smart Molecules Faculty of Science Rikkyo University Toshima Tokyo 171‐8501 Japan

DDS Research Laboratory NOF CORPORATION 3‐3 Chidori‐cho, Kawasaki‐ku Kawasaki Kanagawa 210‐0865 Japan

Funding

Japan Society for the Promotion of Science · Chiba University · Japan Science and Technology Agency · Asahi Glass Foundation · Core Research for Evolutional Science and Technology

References (60)

Show source-provided references
1. 10.1038/nbt.173310.1038/nbt.1733 ↗
2. 10.1073/pnas.161965311410.1073/pnas.1619653114 ↗
3. 10.1016/j.ymthe.2019.02.01210.1016/j.ymthe.2019.02.012 ↗
4. 10.1038/nrd.2017.24310.1038/nrd.2017.243 ↗
5. 10.1038/srep1581010.1038/srep15810 ↗
6. 10.1172/JCI6535110.1172/JCI65351 ↗
7. 10.1016/j.stem.2010.08.01210.1016/j.stem.2010.08.012 ↗
8. 10.1016/j.ymthe.2019.01.01410.1016/j.ymthe.2019.01.014 ↗
9. 10.1038/nature0468810.1038/nature04688 ↗
10. 10.1002/anie.20120326310.1002/anie.201203263 ↗
11. 10.1056/NEJMoa171615310.1056/NEJMoa1716153 ↗
12. 10.1038/nbt.425510.1038/nbt.4255 ↗
13. 10.1002/adhm.20130062910.1002/adhm.201300629 ↗
14. 10.1038/nbt.261210.1038/nbt.2612 ↗
15. 10.1038/nbt.329810.1038/nbt.3298 ↗
16. 10.1021/acs.nanolett.5b0249710.1021/acs.nanolett.5b02497 ↗
17. 10.1002/adma.20150582210.1002/adma.201505822 ↗
18. 10.1002/adma.20160694410.1002/adma.201606944 ↗
19. 10.1021/acs.nanolett.6b0332910.1021/acs.nanolett.6b03329 ↗
20. 10.1016/j.celrep.2018.02.01410.1016/j.celrep.2018.02.014 ↗
21. 10.1002/adma.20180115110.1002/adma.201801151 ↗
22. 10.1016/j.ymthe.2018.03.01010.1016/j.ymthe.2018.03.010 ↗
23. 10.1002/smll.20180509710.1002/smll.201805097 ↗
24. 10.1002/adma.20180774810.1002/adma.201807748 ↗
25. 10.1021/acsnano.6b0844710.1021/acsnano.6b08447 ↗
26. 10.1093/nar/gkl116510.1093/nar/gkl1165 ↗
27. 10.1093/nar/gky108710.1093/nar/gky1087 ↗
28. 10.1073/pnas.161419311410.1073/pnas.1614193114 ↗
29. 10.1073/pnas.181000211510.1073/pnas.1810002115 ↗
30. 10.1073/pnas.180535811510.1073/pnas.1805358115 ↗
31. 10.1021/jacs.9b0315410.1021/jacs.9b03154 ↗
32. 10.1016/S0169-409X(02)00179-510.1016/S0169-409X(02)00179-5 ↗
33. 10.1016/S0891-5849(01)00480-410.1016/S0891-5849(01)00480-4 ↗
34. 10.1021/ja710202610.1021/ja7102026 ↗
35. 10.1002/adhm.20140003910.1002/adhm.201400039 ↗
36. 10.1021/acs.biomac.8b0132110.1021/acs.biomac.8b01321 ↗
37. 10.1021/acs.iecr.9b0066610.1021/acs.iecr.9b00666 ↗
38. 10.1002/adma.20150288810.1002/adma.201502888 ↗
39. 10.1002/adma.20190257510.1002/adma.201902575 ↗
40. 10.1002/adhm.20120043110.1002/adhm.201200431 ↗
41. 10.1517/17425247.2016.115453110.1517/17425247.2016.1154531 ↗
42. 10.1016/j.colsurfb.2016.11.02010.1016/j.colsurfb.2016.11.020 ↗
43. 10.1016/j.heliyon.2018.e0095910.1016/j.heliyon.2018.e00959 ↗
44. 10.1002/anie.20110296510.1002/anie.201102965 ↗
45. 10.1080/10409238.2017.140919110.1080/10409238.2017.1409191 ↗
46. 10.1080/10409238.2018.148880410.1080/10409238.2018.1488804 ↗
47. 10.1073/pnas.172054211510.1073/pnas.1720542115 ↗
48. 10.1248/bpb.b18-0078310.1248/bpb.b18-00783 ↗
49. 10.1016/S0168-3659(99)00114-510.1016/S0168-3659(99)00114-5 ↗
50. 10.1038/mtna.2014.6110.1038/mtna.2014.61 ↗
51. 10.2477/jccj.2018-001210.2477/jccj.2018-0012 ↗
52. 10.1016/j.cplett.2017.07.03210.1016/j.cplett.2017.07.032 ↗
53. 10.7567/1882-0786/ab5e0a10.7567/1882-0786/ab5e0a ↗
54. 10.1038/mt.2013.12410.1038/mt.2013.124 ↗
55. 10.3109/1071754980903139010.3109/10717549809031390 ↗
56. 10.1038/mt.2010.8510.1038/mt.2010.85 ↗
57. 10.1016/S0169-409X(97)00128-210.1016/S0169-409X(97)00128-2 ↗
58. 10.1073/pnas.181127611510.1073/pnas.1811276115 ↗
59. 10.1021/acs.nanolett.8b0291710.1021/acs.nanolett.8b02917 ↗
60. 10.1021/acs.molpharmaceut.8b0037010.1021/acs.molpharmaceut.8b00370 ↗